Navigation Links
MELA Sciences, Inc., a Leader in the Fight Against Melanoma, Participates in the American Society of Dermatologic Surgery Annual Meeting
Date:10/2/2013

ommitted to raising awareness of the disease and helping dermatologists fight this deadly epidemic with MelaFind® as an advanced tool to help in diagnosis," said Robert Coradini, Interim CEO for MELA Sciences. "It is the only FDA approved and CE Marked optical diagnostic device for melanoma detection, which non-invasively and painlessly takes 3-D images of a mole as deep as 2.5mm below the skin's surface with multi-spectral light and analyzes 75 key features with proprietary algorithms to aid dermatologists with useful information in their biopsy decisions of ambiguous moles."

"The results obtained from a MelaFind® exam combined with my expertise in dermatology and knowledge of patient histories helps me to make the best decision for my patients when examining atypical lesions," said Darrell Rigel, MD, Clinical Professor of Dermatology, New York University and recently named Chief Medical Advisor to the Board of Directors of MELA Sciences, Inc. "Using MelaFind®, I can see up to 2.5mm beneath the surface of the skin to obtain information I wouldn't have seen using the naked eye."

MelaFind® has been recognized by the Cleveland Clinic as a Top 10 Medical Innovation for 2013 and was recently featured in The Wall Street Journal. Consumers can learn more about the device or locate a dermatologist with MelaFind® in their area by visiting www.melafind.com.

About MELA Sciences, Inc.
MELA Sciences, Inc. is a medical device company focused on the commercialization of its flagship product, MelaFind® and its further design and development. MelaFind® is a non-invasive tool that provides additional information to dermatologists during melanoma skin examinations. The device uses light from visible to near-infrared wavel
'/>"/>

SOURCE MELA Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Islet Sciences, Inc. Selects NeoStems Manufacturing Subsidiary Progenitor Cell Therapy for Product Manufacturing
2. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
3. Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
4. Nautilus Neurosciences, Inc. Announces a New Approval for CAMBIA® for the Acute Treatment of Migraine
5. Regado Biosciences, Inc. to Present at Needham & Companys 11th Annual Healthcare Conference in New York, NY
6. Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference
7. Pressure BioSciences, Inc. Reaches Agreement with Investors on Initial $600,000 Tranche of $1.2 Million Above-Market Private Placement; Proceeds to Support Continued Commercialization of PCT Product Platform
8. Pressure BioSciences, Inc. Continues Global Sales Reach Expansion with Distribution Agreements for China, Vietnam, Laos, Cambodia, Australia, and New Zealand
9. Jaipal Reddy, Honble Minister of Science and Technology & Earth Sciences, Inaugurates the International Bioenergy Summit in Delhi
10. Pressure BioSciences, Inc. Appoints Conrad F. Mir as Chief Financial Officer
11. A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 This webinar will focus on ... safety assessment in biosimilars. , Regulatory frameworks are evolving ... development, however the complex nature of biopharmaceuticals makes the ... efficacy extremely challenging. Based on the specific aspects of ...
(Date:1/15/2014)... January 15, 2014 The Microcompetition with Foreign ... disease. One of these latent viruses is the Epstein Barr ... (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease that ... study found that RA patients have high concentrations of EBV ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 AudioNotch is ... new therapy for the treatment of tinnitus. Patients listen ... frequency, and over a period of weeks to months, their ... Therapy in two forms: Notched Music and Notched White Noise. ...
(Date:1/14/2014)... CA (PRWEB) January 14, 2014 Histogen, ... the products of cells grown under simulated embryonic conditions, ... license agreement with Suneva Medical, Inc. for physician-dispensed aesthetic ... , This agreement is an amendment to ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... as a finalist in the International Bio 2009 Convention Contest, "Be ... ... April 7, 2009 -- Impact Systems Inc., ( www.ImpactSystems.com ), a ... today announced their Compliance-in-a-Box video has been selected as a finalist ...
... NORTH BRUNSWICK, N.J., April 7 WellGen, Inc. today ... been appointed President and Chief Executive Officer. ... who was serving as interim Chief Executive Officer. ... and as President and Chief Financial Officer of Amphion ...
... Full Control of the Entire Clinical Trial Registration ... while Adhering to Changing Regulatory Requirements; Two Top-Ten ... Trial Registration and Results Disclosure ProcessesNEW YORK, April ... ), a leading services firm that ...
Cached Biology Technology:Impact Systems' Compliance-in-a-Box™ Video is Announced as "Be the Buzz of Bio" Contest Finalist 2Impact Systems' Compliance-in-a-Box™ Video is Announced as "Be the Buzz of Bio" Contest Finalist 3Dr. Roddy Carter Named President and Chief Executive Officer of WellGen, Inc. 2Dr. Roddy Carter Named President and Chief Executive Officer of WellGen, Inc. 3Intrasphere Technologies Releases Version 1.5 of Its PharmaCM Clinical Trial Registration Solution Powered by Microsoft 2Intrasphere Technologies Releases Version 1.5 of Its PharmaCM Clinical Trial Registration Solution Powered by Microsoft 3Intrasphere Technologies Releases Version 1.5 of Its PharmaCM Clinical Trial Registration Solution Powered by Microsoft 4
(Date:4/23/2014)... Valley, NY. (Apr. 23, 2014) People who have ... potential to restore neurological function. However, a study conducted ... issue of Cell Transplantation , but is currently ... http://www.ingentaconnect.com/content/cog/ct/pre-prints/content-ct1168Chen , has found that when one group ... cells (PBSCs) injected directly into the brain and a ...
(Date:4/23/2014)... transformed the energy landscape in the U.S., but ... among the energy industry, residents and agricultural interests ... that degraded water quality is a potential risk ... appears in the ACS journal Environmental Science ... colleagues point out that a major criticism of ...
(Date:4/23/2014)... coined term for novels and films which focus on the ... shows how these fictions serve as a mental laboratory that ... and imagine other living conditions. , "Global warming is ... it is also a cultural phenomenon in which meaning is ... we see. And there are so many of them now ...
Breaking Biology News(10 mins):Autologous stem cell therapy improves motor function in chronic stroke victims 2How to avoid water wars between 'fracking' industry and residents 2Fiction prepares us for a world changed by global warming 2Fiction prepares us for a world changed by global warming 3
... for Microbiology (ASM) Abbott Laboratories Award in Clinical ... Shearer, Ph.D., Chief, Cell Mediated Immunity Section, Experimental ... Health (NIH), Bethesda, MD, for his research on ... this award recognizes a distinguished scientist in clinical ...
... PhD, associate professor of chemistry at New Jersey ... awarded a patent today for a novel composition ... Perfluoro-Phthalocyanine Compounds" (US Patent Number 7,670,684) discloses a ... materials are comprised of organic scaffolds with metal ...
... one of the world,s most widely used pesticides, wreaks ... emasculating three-quarters of them and turning one in 10 ... of California, Berkeley, biologists. The 75 percent that ... inability to reproduce in the wild, reports UC Berkeley,s ...
Cached Biology News:American Society for Microbiology honors Gene M. Shearer 2NJIT researcher awarded patent for hydrophobic, corrosion-resistant coating 2Pesticide atrazine can turn male frogs into females 2Pesticide atrazine can turn male frogs into females 3Pesticide atrazine can turn male frogs into females 4
Request Info...
"BioTracker 6X Bromophenol Blue Tracking Dye is composed of 60% St DI H2O, 30% Glycerol, 10% 10XTE, 0.25% BPB Dye and 0.85% SDS....
Agarose, low melting/gelling temperature, high MW separation (>1000 bp), 25 g. Suitable for enzymatic modifications. Nuclease-free.Gel point: 24-30 C, EEO (-mr): 300 gm/cm2. Category: Nucleotides &...
Request Info...
Biology Products: